{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T13:01:55Z","timestamp":1792587715759,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007924","name":"Bengbu Medical College","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007924","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurology and Neurosurgery"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.clineuro.2024.108258","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T17:51:09Z","timestamp":1711475469000},"page":"108258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases"],"prefix":"10.1016","volume":"240","author":[{"given":"Jiali","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqiong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhizhen","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yichuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changzheng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clineuro.2024.108258_bib1","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1002\/cncr.30000","article-title":"Risk of brain metastases in patients with nonmetastatic lung cancer: analysis of the Metropolitan Detroit Surveillance, Epidemiology, and End Results (SEER) data","volume":"122","author":"Goncalves","year":"2016","journal-title":"Cancer"},{"issue":"11","key":"10.1016\/j.clineuro.2024.108258_bib2","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1007\/s00330-023-09709-7","article-title":"Multiregional radiomics of brain metastasis can predict response to EGFR-TKI in metastatic NSCLC","volume":"33","author":"Fan","year":"2023","journal-title":"Eur. Radiol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108258_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.clineuro.2024.108258_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105583","article-title":"EGFR mutation mediates resistance to EGFR tyrosine kinase inhibitors in NSCLC: from molecular mechanisms to clinical research","volume":"167","author":"Dong","year":"2021","journal-title":"Pharm. Res."},{"issue":"6","key":"10.1016\/j.clineuro.2024.108258_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.2217\/fon-2018-0736","article-title":"Tumor clonality and resistance mechanisms in EGFR mutation-positive non-small-cell lung cancer: implications for therapeutic sequencing","volume":"15","author":"Kohsaka","year":"2019","journal-title":"Future Oncol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108258_bib6","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1525-1578(10)60569-7","article-title":"Rapid polymerase chain reaction-based detection of epidermal growth factor receptor gene mutations in lung adenocarcinomas","volume":"7","author":"Pan","year":"2005","journal-title":"J. Mol. Diagn."},{"issue":"13","key":"10.1016\/j.clineuro.2024.108258_bib7","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1158\/1078-0432.CCR-06-0462","article-title":"Exon 19 deletion mutations of epidermal growth factor receptor are associated with prolonged survival in non-small cell lung cancer patients treated with gefitinib or erlotinib","volume":"12","author":"Jackman","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"3 Pt 1","key":"10.1016\/j.clineuro.2024.108258_bib8","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1078-0432.CCR-05-1846","article-title":"Clinical course of patients with non-small cell lung cancer and epidermal growth factor receptor exon 19 and exon 21 mutations treated with gefitinib or erlotinib","volume":"12","author":"Riely","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"12","key":"10.1016\/j.clineuro.2024.108258_bib9","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/j.jtho.2020.08.020","article-title":"Refined stratification based on baseline concomitant mutations and longitudinal circulating tumor DNA monitoring in advanced EGFR-mutant lung adenocarcinoma under gefitinib treatment","volume":"15","author":"Duan","year":"2020","journal-title":"J. Thorac. Oncol."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108258_bib10","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1158\/0008-5472.CAN-20-0999","article-title":"Radiomic detection of EGFR mutations in NSCLC","volume":"81","author":"Rossi","year":"2021","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108258_bib11","doi-asserted-by":"crossref","first-page":"3458","DOI":"10.7150\/ijbs.71046","article-title":"The progress of multimodal imaging combination and subregion based radiomics research of cancers","volume":"18","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108258_bib12","doi-asserted-by":"crossref","first-page":"8905","DOI":"10.1038\/s41598-020-65470-7","article-title":"Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer","volume":"10","author":"Ahn","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.clineuro.2024.108258_bib13","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1146\/annurev-pathol-011110-130206","article-title":"EGFR mutations and lung cancer","volume":"6","author":"da Cunha Santos","year":"2011","journal-title":"Annu. Rev. Pathol."},{"issue":"22","key":"10.1016\/j.clineuro.2024.108258_bib14","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.2217\/fon-2021-0218","article-title":"Real-world characteristics and outcomes of advanced non-small-cell lung cancer patients with EGFR exon 19 deletions or exon 21 mutations","volume":"17","author":"Winfree","year":"2021","journal-title":"Future Oncol."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108258_bib15","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.21037\/jtd.2017.07.57","article-title":"Correlation between EGFR mutation status and the incidence of brain metastases in patients with non-small cell lung cancer","volume":"9","author":"Li","year":"2017","journal-title":"J. Thorac. Dis."},{"issue":"3","key":"10.1016\/j.clineuro.2024.108258_bib16","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lungcan.2012.09.006","article-title":"Impact of age on epidermal growth factor receptor mutation in lung cancer","volume":"78","author":"Ueno","year":"2012","journal-title":"Lung Cancer"},{"issue":"11","key":"10.1016\/j.clineuro.2024.108258_bib17","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1007\/s12094-023-03286-3","article-title":"Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer","volume":"25","author":"Nadal","year":"2023","journal-title":"Clin. Transl. Oncol."},{"issue":"7","key":"10.1016\/j.clineuro.2024.108258_bib18","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1038\/bjc.2013.511","article-title":"EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice","volume":"109","author":"Gahr","year":"2013","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.clineuro.2024.108258_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4103\/0019-509X.117023","article-title":"Epidermal growth factor receptor mutation subtypes and geographical distribution among Indian non-small cell lung cancer patients","volume":"50","author":"Choughule","year":"2013","journal-title":"Indian J. Cancer"},{"issue":"44","key":"10.1016\/j.clineuro.2024.108258_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001949","article-title":"The difference of clinical characteristics between patients with exon 19 deletion and those with L858R mutation in nonsmall cell lung cancer","volume":"94","author":"Zhang","year":"2015","journal-title":"Medicine (Baltimore)"},{"issue":"9","key":"10.1016\/j.clineuro.2024.108258_bib21","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1007\/s00432-020-03296-6","article-title":"Non-small cell lung cancer patients with ex19del or exon 21 L858R mutation: distinct mechanisms, different efficacies to treatments","volume":"146","author":"Li","year":"2020","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.clineuro.2024.108258_bib22","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1200\/JCO.2006.07.3585","article-title":"Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer","volume":"25","author":"Sequist","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.clineuro.2024.108258_bib23","first-page":"67","article-title":"Known and putative mechanisms of resistance to EGFR targeted therapies in NSCLC patients with EGFR mutations-a review","volume":"4","author":"Stewart","year":"2015","journal-title":"Transl. Lung Cancer Res."},{"key":"10.1016\/j.clineuro.2024.108258_bib24","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.lungcan.2023.01.002","article-title":"Primary endpoints to assess the efficacy of novel therapeutic approaches in epidermal growth factor receptor-mutated, surgically resectable non-small cell lung cancer: a review","volume":"177","author":"Blakely","year":"2023","journal-title":"Lung Cancer"},{"issue":"5","key":"10.1016\/j.clineuro.2024.108258_bib25","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3390\/cancers9050052","article-title":"Epidermal growth factor receptor cell proliferation signaling pathways","volume":"9","author":"Wee","year":"2017","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.clineuro.2024.108258_bib26","doi-asserted-by":"crossref","first-page":"4538","DOI":"10.1007\/s00330-020-07614-x","article-title":"Radiomics signature of brain metastasis: prediction of EGFR mutation status","volume":"31","author":"Wang","year":"2021","journal-title":"Eur. Radiol."},{"issue":"8","key":"10.1016\/j.clineuro.2024.108258_bib27","doi-asserted-by":"crossref","first-page":"4545","DOI":"10.1007\/s00330-020-06745-5","article-title":"Radiomics analysis of lung CT image for the early detection of metastases in patients with breast cancer: preliminary findings from a retrospective cohort study","volume":"30","author":"Qi","year":"2020","journal-title":"Eur. Radiol."},{"issue":"2","key":"10.1016\/j.clineuro.2024.108258_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1148\/radiol.13132195","article-title":"Behind the numbers: decoding molecular phenotypes with radiogenomics--guiding principles and technical considerations","volume":"270","author":"Kuo","year":"2014","journal-title":"Radiology"},{"key":"10.1016\/j.clineuro.2024.108258_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.lungcan.2019.03.025","article-title":"Radiomics signature: a potential and incremental predictor for EGFR mutation status in NSCLC patients, comparison with CT morphology","volume":"132","author":"Tu","year":"2019","journal-title":"Lung Cancer"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108258_bib30","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000013963","article-title":"Can CT radiomic analysis in NSCLC predict histology and EGFR mutation status?","volume":"98","author":"Digumarthy","year":"2019","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"10.1016\/j.clineuro.2024.108258_bib31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1186\/s40001-023-01361-7","article-title":"Development and testing of a random forest-based machine learning model for predicting events among breast cancer patients with a poor response to neoadjuvant chemotherapy","volume":"28","author":"Jin","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"20","key":"10.1016\/j.clineuro.2024.108258_bib32","doi-asserted-by":"crossref","first-page":"3753","DOI":"10.3390\/molecules24203753","article-title":"Quantitative analysis of major metals in agricultural biochar using laser-induced breakdown spectroscopy with an adaboost artificial neural network algorithm","volume":"24","author":"Duan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.clineuro.2024.108258_bib33","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.neuroimage.2014.10.002","article-title":"Alzheimer\u2019s Disease Neuroimaging Initiative. Machine learning framework for early MRI-based Alzheimer\u2019s conversion prediction in MCI subjects","volume":"104","author":"Moradi","year":"2015","journal-title":"Neuroimage"}],"container-title":["Clinical Neurology and Neurosurgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001458?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0303846724001458?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T07:04:41Z","timestamp":1714115081000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0303846724001458"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":33,"alternative-id":["S0303846724001458"],"URL":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108258","relation":{},"ISSN":["0303-8467"],"issn-type":[{"value":"0303-8467","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distinguishing EGFR mutation molecular subtypes based on MRI radiomics features of lung adenocarcinoma brain metastases","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurology and Neurosurgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clineuro.2024.108258","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108258"}}